SE461892B - Oljeloeslig komposition av vitamin b -butyrat - Google Patents

Oljeloeslig komposition av vitamin b -butyrat

Info

Publication number
SE461892B
SE461892B SE8301565A SE8301565A SE461892B SE 461892 B SE461892 B SE 461892B SE 8301565 A SE8301565 A SE 8301565A SE 8301565 A SE8301565 A SE 8301565A SE 461892 B SE461892 B SE 461892B
Authority
SE
Sweden
Prior art keywords
oil
vitamin
butyrate
fatty acid
fifi
Prior art date
Application number
SE8301565A
Other languages
English (en)
Swedish (sv)
Other versions
SE8301565L (sv
SE8301565D0 (sv
Inventor
Y Yamamoto
T Okada
S Morioka
T Kaneko
Original Assignee
Sato Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sato Pharma filed Critical Sato Pharma
Publication of SE8301565D0 publication Critical patent/SE8301565D0/xx
Publication of SE8301565L publication Critical patent/SE8301565L/
Publication of SE461892B publication Critical patent/SE461892B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8301565A 1982-05-31 1983-03-22 Oljeloeslig komposition av vitamin b -butyrat SE461892B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57091466A JPS58208215A (ja) 1982-05-31 1982-05-31 脂溶性ビタミン配合油溶組成物

Publications (3)

Publication Number Publication Date
SE8301565D0 SE8301565D0 (sv) 1983-03-22
SE8301565L SE8301565L (sv) 1983-12-01
SE461892B true SE461892B (sv) 1990-04-09

Family

ID=14027151

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8301565A SE461892B (sv) 1982-05-31 1983-03-22 Oljeloeslig komposition av vitamin b -butyrat

Country Status (6)

Country Link
JP (1) JPS58208215A (de)
CH (1) CH656531A5 (de)
DE (1) DE3311008C2 (de)
FR (1) FR2527440B1 (de)
GB (1) GB2120935B (de)
SE (1) SE461892B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS63130535A (ja) * 1986-11-19 1988-06-02 Nisshin Kagaku Kk 経口投与用抗ヒスタミン剤
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
GB2335854B (en) 1997-01-30 2001-04-25 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8014M (de) * 1968-01-09 1970-07-27
US3962436A (en) * 1969-06-03 1976-06-08 Sumitomo Chemical Company, Limited Pharmaceutical compositions having controlled rate of gastro-intestinal absorption
NL7012460A (de) * 1970-08-22 1972-02-24
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations

Also Published As

Publication number Publication date
SE8301565L (sv) 1983-12-01
SE8301565D0 (sv) 1983-03-22
JPH044299B2 (de) 1992-01-27
GB8307543D0 (en) 1983-04-27
DE3311008C2 (de) 1986-04-10
JPS58208215A (ja) 1983-12-03
CH656531A5 (de) 1986-07-15
GB2120935B (en) 1985-10-23
FR2527440A1 (fr) 1983-12-02
FR2527440B1 (fr) 1987-05-15
DE3311008A1 (de) 1983-12-01
GB2120935A (en) 1983-12-14

Similar Documents

Publication Publication Date Title
Thompson A biochemical approach to the problem of multiple sclerosis
Rosenman et al. Behavior patterns, blood lipids, and coronary heart disease
JP2677554B2 (ja) 乾燥した微粒子のさらさらした安定なトコフエロール
Williams Quick test for comparing two populations with bivariate data
DE60018372T2 (de) Oralzusammensetzung als mikroemulsion von silybin
Woodall et al. Nutrition of salmonoid fishes: XIII. The α-tocopherol requirement of Chinook salmon
Yang et al. Effect of high levels of dietary vitamin E on liver and plasma lipids and fat soluble vitamins in rats
KR840005339A (ko) 지용성물질을 함유한 수용액의 제조방법
DE69723671T2 (de) Cyclosüporin formulierung
GB1386260A (en) Shortening for highly aerated creamy frostings
EP0196085B1 (de) Ubidecarenon enthaltende Mittel mit erhöhter Absorption
Kattner et al. Lipid composition of some typical North Sea copepods
SE461892B (sv) Oljeloeslig komposition av vitamin b -butyrat
Stanley-Samuelson et al. Arachidonic and other tissue fatty acids of Culex pipiens reared with various concentrations of dietary arachidonic acid
Lawrence et al. An incident of elevated levels of unsaturated free fatty acids in mussels from Nova Scotia and their toxic effect in mice after intraperitoneal injection
Noble et al. Metabolism of the yolk phospholipids by the developing chick embryo
SI9720010B (sl) Ciklosporin vsebujoči mehki kapsulni pripravki
Gallo‐Torres et al. Distribution and metabolism of two orally administered esters of tocopherol
Brooks et al. Effects of air, ozone, and nitrogen dioxide exposure on the oxidation of corn and soybean lipids
Saldanha Race mixture among northeastern Brazilian populations
KR102414627B1 (ko) 효과적인 토코트리에놀 전달을 위한 제형
US2895878A (en) Compositions containing stabilized vitamin a materials
Yuan et al. Comparative analysis of essential bioactive components of oils originating from three Chinese Loess Plateau wild crops
Tusing et al. The chronic dermal toxicity of a series of polyethylene glycols
Mosbah et al. Antioxidant and anti-hemolitic activities of Algerian Nigella sativa total oil and its neutral lipid fraction

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8301565-1

Format of ref document f/p: F

NUG Patent has lapsed